UCB Ventures and Ysios Capital have led a EUR 50m Series A for SpliceBio, a Spanish biotech company working on protein splicing for gene therapies.
French sponsor seeks to attract state-backed LPs for new strategy targeting ESG-focused startups
Director appointments include Rutland Partners' Matt Hamilton-Allen, who joins the investment team
New vehicle exceeded target by more than USD 300m; aims for up to 20% exposure to European debt
New vehicle will invest at the crossover of health care, life sciences and tech with EUR 5m-50m tickets